PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25726N0140FIT VISN 17 FECAL immunochemical — Polymedco Cancer Diagnostic Products LLC

Polymedco Cancer Diagnostic Products LLC holds $13.0M across 407 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25725D0017. Recompete timing centers on the Jan 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

257-Network Contract Office 17 (36C257)

Awarding office

Polymedco Cancer Diagnostic Products LLC

Recipient

Jan 14, 2027

PoP end

$615K

Obligated

$615K

Potential

492110

NAICS

R604

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Polymedco Cancer Diagnostic Products LLC — $90

Contract facts

Federal

Contract number36C25726N0140

Also listed as36C257-26-N-0140

Also listed as36C25725D0017-36C25726N0140

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentPolymedco Cancer Diagnostic Products LLC

CAGE6U4P6

UEIJYKKQ1NLJRX7

NAICS492110

No full NAICS 492110 intel page yet. Browse NAICS intelligence

PSCR604

Parent IDIQ / IDV36C25725D0017

Place of performanceCORTLANDT MANOR NY

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startJan 15, 2026

PoP end (current)Jan 14, 2027

Obligated$615K

Current value$615K

Potential value$615K

VISN 17 FECAL IMMUNOCHEMICAL TEST (FIT) KIT MAILING SERVICE - ORDERING PERIOD 2 is a federal award for 257-Network Contract Office 17 (36C257) held by Polymedco Cancer Diagnostic Products LLC. Estimated value $615K ($615K obligated). Current period of performance ends Jan 14, 2027. Place of performance: CORTLANDT MANOR NY.

VISN 17 FECAL IMMUNOCHEMICAL TEST (FIT) KIT MAILING SERVICE - ORDERING PERIOD 2

Recompete timing

Public

● Expiring in 129 days

Current PoP ends Jan 14, 2027 (129 days remaining). Agencies typically plan 12–18 months ahead — at 4.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Polymedco Cancer Diagnostic Products LLC — $13.0M obligated across 407 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($13.0M) · all agencies · Top 3 shown (50%); remaining ~50% is other agencies.

Department of Veterans Affairs (VA)$5.8M · 45%Department of Defense (DOD)$546K · 4%Department of Health and Human Services (HHS)$143K · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C24E22F0001

FOBT ANALYZER & SUPPLIES

$504K

Sep 30, 2026

36C25726N0007

NTX FECAL OCCULT BLOOD TESTING CPRR

$165K

Sep 30, 2026

36C24826N0438

CANCER SCREENING

$440K

Mar 31, 2027

36C24826N0256

IFOBT REAGENTS

$133K

May 12, 2027

36C24426N0755

MAILED FIT PROGRAM: PATIENT NAVIGATION SERVICES

$368K

Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25726N0140?

36C25726N0140 (FIT VISN 17 FECAL immunochemical) is a 257-Network Contract Office 17 (36C257) award with a potential value of $615K, currently held by Polymedco Cancer Diagnostic Products LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-26-N-0140?

36C257-26-N-0140 is the dashed form of PIID 36C25726N0140 (FIT VISN 17 FECAL immunochemical), held by Polymedco Cancer Diagnostic Products LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25726N0140?

257-Network Contract Office 17 (36C257) awarded 36C25726N0140 to Polymedco Cancer Diagnostic Products LLC (potential $615K).

Who is the incumbent on 36C25726N0140?

Polymedco Cancer Diagnostic Products LLC is the incumbent with $13.0M across 407 related awards in SCOUT’s public footprint. The current period of performance ends Jan 14, 2027.

When does Polymedco Cancer Diagnostic Products LLC’s 36C25726N0140 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C25726N0140 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Apr 10, 2026